Navigation Links
Center for Molecular Medicine Among First Labs in Nation to Offer Groundbreaking Test to Aid in Treatment of Colorectal Cancer
Date:12/12/2007

GRAND RAPIDS, Mich., Dec. 12 /PRNewswire/ -- The Center for Molecular Medicine (CMM) today announced it is one of the first laboratories in the nation to offer a new test to help guide the treatment of metastatic colorectal cancer (CRC; also called stage IV or "advanced").

The CMM (http://www.cmmdx.org) is offering the CellSearch(TM) System from Veridex (http://www.veridex.com) to physicians as a vital new tool in managing patients with metastatic CRC.

Recently approved by the FDA for the monitoring of CRC, the CellSearch System identifies and counts circulating tumor cells (CTCs) in a blood sample to predict progression-free and overall-survival in patients, and can do so earlier than the current standard of care.

Testing for CTCs with the CellSearch System, in conjunction with other clinical methods for monitoring, can help physicians assess disease progression, thereby guiding more informed care decisions earlier. The CMM began providing FDA-approved CellSearch testing services for metastatic breast cancer patients earlier this year.

The CellSearch System is the first diagnostic test to automatically identify and count CTCs, cancer cells that detach from solid tumors and enter the bloodstream. The system's specificity, sensitivity and reproducibility allow assessment of CTCs as early as the first cycle of treatment to help evaluate disease progression sooner.

According to the American Cancer Society, CRC claims approximately 55,000 lives annually, the vast majority of which are a result of recurrent metastatic disease. Metastatic CRC occurs when tumor cells spread to other locations in the body and grow. Although there are several options for the treatment of metastatic CRC, oncologists often have to wait months before they can determine if a specific treatment has been beneficial to the patient.

"We are very pleased to be able to add CellSearch colorectal cancer testing to our growing menu of cutting-edge diagnostic services available to physicians. The CellSearch cancer tests represent an important advance in how breast and colorectal cancer can be detected and managed over the long term," said CMM Executive Director Dr. Daniel H. Farkas. "It's an important new capability for the region's medical community, and another significant step forward in the growth of the CMM as a unique resource in the rapidly expanding field of molecular medicine."

The CellSearch System, which is distributed by Veridex, a Johnson & Johnson company, was cleared by the FDA in January 2004 as an in vitro diagnostic test to aid in the identifying and counting of CTCs in a blood sample. Pricing for the test is $495 and CMM is working with area insurance providers regarding coverage. Physicians interested in obtaining more information may contact CMM directly at 616-391-4330 or visit http://www.cmmdx.org/physicians.

About the CMM

The Center for Molecular Medicine, a joint venture between Grand Rapids, Mich.-based Spectrum Health and Van Andel Institute (VAI), brings West Michigan a cutting-edge laboratory that will aid in early diagnoses and enhance personalized medicine. It offers 21st century molecular technologies for investigation of complex diseases like cancer, heart disease, mental illness and other conditions at the DNA, RNA and protein levels. The Center brings new and increased opportunities for diagnostics and pharmaceutical companies to conduct trials in a world-class medical and clinical research environment. For more information, visit http://www.cmmdx.org.


'/>"/>
SOURCE Center for Molecular Medicine
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
2. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
3. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
4. UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees
5. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
6. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
7. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
8. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
9. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
10. Kaiser Permanente Colorado Opens Center for Health Dissemination and Implementation Research
11. Beaumont Technology Usability Center To Offer Training For Medical Technology Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... (PRWEB) , ... May 23, 2016 , ... The need for blood donations in South ... week by the South Texas Blood & Tissue Center, blood donations are on the decline. ... years, and they are down 21 percent in South Texas in the last four years ...
(Date:5/23/2016)... England , May 23, 2016 ... May 25 th at 10:15 a.m. ET before the ... the role genetically engineered mosquitos can play in controlling the ... carrier of the Zika virus.      (Logo: ... engineered male mosquito with a self-limiting gene. Trials in ...
(Date:5/23/2016)... Alto, CA (PRWEB) , ... May 23, 2016 ... ... and public interest organization focused on molecular nanotechnology, announced the winners for the ... of pioneer physicist Richard Feynman, are given in two categories, one for experiment ...
(Date:5/20/2016)... ... May 20, 2016 , ... Kablooe Design, a leading provider of product ... official 25th anniversary of the business. “We have worked hard to build long-term relationships,” ... for the privilege and honor of serving their product design and development needs through ...
Breaking Biology Technology:
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
(Date:4/13/2016)... -- IMPOWER physicians supporting Medicaid patients in Central ... in telehealth thanks to a new partnership with higi. ... patients can routinely track key health measurements, such as ... when they opt in, share them with IMPOWER clinicians ... retail location at no cost. By leveraging this data, ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):